Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies

• DOI: 10.1016/j.intimp.2024.111863
• Publication Date: 2024-03-15T07:23:38Z
• Authors: Zi-Yi Wang; Bin Xu; Lu-Na Wang; Xiao-Dong Zhu; Cheng Huang; Ying-Hao Shen; Hui Li; Mei-Ling Li; Jian Zhou; Jia Fan; Hui-Chuan Sun
• Keywords: Progression-free survival

Lymphocyte-related factors were associated with survival outcome of different types cancers. Nevertheless, the association between lymphocytes-related and tumor response immunotherapy remains unclear.